A Breast Cancer Awareness Month conversation about risk beyond lifestyle
Last year, I was diagnosed with breast cancer.
Like many women, I had paid close attention to the risk factors I could influence. I ate well, exercised regularly, did not smoke, limited alcohol, and nursed each of my children for more than a year. I had done so much of what we are encouraged to do. My diagnosis was a difficult reminder that healthy choices matter, but they do not reduce risk to zero.
October is Breast Cancer Awareness Month. For me, awareness now means more than a pink ribbon or a reminder to book a mammogram. It means understanding the whole risk picture, including factors we cannot see or change. Two of the most important are breast density and calculated lifetime risk.
Risk is not a report card
Nutrition, physical activity, avoiding smoking, limiting alcohol,
maintaining a weight that supports health, and breastfeeding can all contribute to risk reduction. These modifiable risks remain worthwhile. But breast cancer is not proof that someone made poor choices, and prevention is never a guarantee.
Age, genetics, family history, reproductive and hormonal history, prior
breast biopsies, certain high-risk breast changes, and breast density may also shape risk. Some women who develop breast cancer have no obvious family history. That is why a fuller assessment matters.
What breast density means
Breasts contain fatty, glandular, and fibrous tissue. Breast density describes the proportion of fibrous and glandular tissue compared with fatty tissue. It is not related to how firm your breasts feel, and it cannot be determined by looking at or examining them. It is assessed on a mammogram.
Mammography reports generally use four BI-RADS density categories:
- A: almost entirely fatty
- B: scattered areas of fibroglandular density
- C: heterogeneously dense
- D: extremely dense
Categories C and D are considered dense. Dense tissue matters for two separate reasons. First, it is an independent risk factor for developing breast cancer. Second, dense tissue and many cancers both appear white on a mammogram, which can make a cancer more difficult to see. Density can therefore affect both risk and the sensitivity of screening.
Having dense breasts does not mean that you will develop breast cancer. It means density should be considered alongside your other risk factors when you and your healthcare team discuss an appropriate screening plan.
Why lifetime risk can change the conversation
A lifetime risk estimate combines several pieces of information to estimate the chance of developing breast cancer over time. It is not a diagnosis or a prediction of what will happen to one individual. Its value is that it can identify people whose screening or prevention conversation may need to differ from the average-risk pathway.
The Tyrer-Cuzick Risk Assessment, also called the IBIS model, estimates 10-year and lifetime breast cancer risk. The current model can include age, reproductive history, menopausal status, hormone therapy use, height and weight, family history on both sides of the family, genetic information when known, prior breast biopsy findings, and breast density.
The accuracy of any risk calculator depends on accurate and complete information. Different tools may also produce different estimates because they use different variables and populations. A result should be reviewed with a knowledgeable healthcare professional, especially if it may influence imaging, genetic counselling, medication, or other preventive decisions.
Important: The Tyrer-Cuzick tool is intended to estimate the risk of a first breast cancer. It is not designed for someone who has already been diagnosed with breast cancer. After a diagnosis, surveillance and future-risk planning should be individualized with the treating team.
This article is for educational purposes only and is not a substitute for individualized medical advice, diagnosis, or treatment. Speak with a qualified healthcare professional about symptoms or health concerns.
